NY-WEA-GRP-POLICIES
5.5.2022 13:07:06 CEST | Business Wire | Press release
The Women’s Entrepreneurship Accelerator (WEA) today announced the publication of an Advocacy Brief titled “Procurement’s strategic value: Why gender-responsive procurement makes business sense” which presents compelling evidence of the benefits for strengthening the participation of women in private sector supply chains in realizing inclusive economic growth and sustainable development.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220505005120/en/
Developed by UN Women and funded by Mary Kay Inc. in support of WEA, the Advocacy Brief highlights the rollback on progress in achieving gender equality as a result of the COVID-19 pandemic, as well as how increasing levels of economic insecurity, supply chain interruptions and unprecedented climate and environmental shocks have a disproportionate impact on women given their unequal position in society.
The publication echoes previous studies that show that economies have better opportunities to grow and are more resilient to crises if women and men have equal rights.1 However, huge challenges remain. Women entrepreneurs continue to face many obstacles including lack of access to capital on both domestic and international markets; fewer entrepreneurship networks compared with men; and policies that discourage female labor market participation.2 Globally, while one in three businesses are owned by women, 3 women only win an estimated one percent of the global spend of large corporations .4 Unequal gender laws also hinder women’s economic opportunity. For instance, nearly 2.4 billion women of working age still do not enjoy the same economic rights as men.5 Despite these statistics, women entrepreneurs remain a solution for many challenges the world faces today and the evidence shows there is a direct correlation between an increase in women entrepreneurship and economic growth, sustainable development, and more inclusive and resilient societies.6
The data presented in the Advocacy Brief outline how the adoption of gender-responsive (GRP) policies and practices through procurement processes is a strategic lever to mitigate the impact of the structural barriers women face and at the same time improve businesses and strengthen economies. The Advocacy Brief cautions that failing to adopt GRP is a wasted opportunity. The evidence is clear. Reducing gender inequalities is good for business and is smart economics.
“Gender-responsive procurement affects corporate profitability, risk mitigation, innovation, and sustainability. When women entrepreneurs are excluded from the procurement pipeline, companies risk leaving a considerable amount of talent, creativity, and expertise on the table. GRP is a winning business strategy as well as a powerful catalyst for change,” said Deborah Gibbins, Chief Operating Officer, Mary Kay, Inc., and inceptor of WEA.
To inform the Advocacy Brief, UN Women engaged over 350 stakeholders in 2021, of which over 150 private sector companies were represented, and incorporated 7 case studies on companies’ procurement journeys to create an evidence base for why businesses should adopt gender-responsive procurement. Stakeholder engagement took the form of interviews, a survey and a community of practice, which benefitted from dissemination across a wide range of networks, including the membership and networks of UN Global Compact’s (UNGC).
Companies reported that GRP leads to:
- Increased revenue and reduced procurement spend,
- Greater supplier availability and resilience,
- Strengthened brand reputation,
- More innovation and adaptability,
- Improved service delivery due to greater agility, and
- Strengthened markets through local economic development and inclusive growth.
As the Advocacy Brief notes “inclusive and sustainable development is paramount for businesses seeking to both stabilize themselves in a volatile economy and benefit from its future growth. Widening gender inequalities hurt all companies, including women entrepreneurs vital to robust and resilient supply chains and the businesses that rely on them.”
Reflecting the increased focus on environmental, social and governance (ESG) issues by companies, the Advocacy Brief notes how “the implementation of GRP allows companies to practice and institutionalize ESG values and importantly contribute to women’s empowerment and the Sustainable Development Goals (SDGs). Through the adoption of GRP principles, businesses can make progress towards multiple goals, including gender equality (SDG 5) and reduced inequalities (SDG 10) in addition to responsible consumption and production (SDG 12), eliminating poverty (SDG 1) and decent work and economic growth (SDG 8).”
“Achieving the Sustainable Development Goals is not something that can be done by women alone, or by business alone, or by government alone. The only way for us to be able to really make progress is if all – business included – work together towards a common purpose,” said Anita Bhatia , Assistant Secretary-General and Deputy Executive Director of UN Women.
Through the release of this report WEA calls on the private sector to adopt GRP strategies and integrate women into global value chains as a vehicle to advance the SDGs. This makes business sense while at the same time advances women’s economic empowerment which benefits economies and societies at large.
The Advocacy Brief is available here .
About the Women’s Entrepreneurship Accelerator
The Women’s Entrepreneurship Accelerator (WEA) is a multi-stakeholder partnership on women’s entrepreneurship established during UNGA 74. It convenes six UN agencies, International Labour Organization (ILO), International Trade Centre (ITC), International Telecommunication Union (ITU), UN Development Programme (UNDP), UN Global Compact (UNGC), UN Women and Mary Kay Inc. to empower 5 million women entrepreneurs by 2030.
The ultimate goal of the initiative is to maximize the development impact of women entrepreneurship in achieving the Sustainable Development Goals (SDGs) by creating an enabling ecosystem for women entrepreneurs around the world. The Accelerator exemplifies the transformational power of a multi-partnership of unique magnitude to harness the potential of women entrepreneurs. Learn more at we-accelerate. Follow us: Twitter (We_Accelerator), Instagram (@we_accelerator), Facebook (@womensentrepreneurshipaccelerator), LinkedIn (@womensentrepreneurshipaccelerator)
1 World Development Report. 2012: Gender Equality and Development: https://openknowledge.worldbank.org/handle/10986/4391 . |
2 European Commission and OECD Policy Brief on Women’s Entrepreneurship. 2017: https://www.oecd.org/cfe/smes/Policy-Brief-on-Women-s-Entrepreneurship.pdf |
3 World Bank. 2020. Enterprise Surveys, World Bank Gender Data Portal: https://www.worldbank.org/en/data/datatopics/gender |
4 Vazquez, E.A. and A.J. Sherman. 2013. Buying for Impact: How to Buy from Women and Change the World. Charleston, USA: Advantage |
5 World Bank Group. 2022.. Women, Business and the Law 2022. Washington, DC: World Bank |
6 UN Women Facts and Figures: Economic Empowerment: https://www.unwomen.org/en/what-we-do/economic-empowerment/facts-and-figures |
View source version on businesswire.com: https://www.businesswire.com/news/home/20220505005120/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Biocytogen Launches AI-Powered RenSuper™ Platform and Industry-First Fully Automated Antibody Discovery Infrastructure26.5.2026 14:00:00 CEST | Press release
Biocytogen today announced the launch of RenSuper Workstation, a next-generation AI-powered antibody discovery platform providing off-the-shelf access to a large-scale, experimentally validated library of fully human therapeutic antibody sequences, together with the RenSuper High-Throughput Antibody Manufacturing Automation Center, a fully automated infrastructure designed to accelerate antibody validation and production. Built on Biocytogen’s proprietary RenMice® platforms, RenSuper establishes a closed-loop antibody discovery engine combining in vivo immune repertoires, AI-driven candidate selection, automated experimental validation, and scalable manufacturing infrastructure. The platform supports the discovery and development of monoclonal antibodies, bispecifics, multispecifics, antibody-drug conjugates (ADCs), VHHs, and other advanced therapeutic modalities, significantly reducing the time and risk associated with antibody discovery. RenSuper Workstation: AI-Powered One-Click Tar
ViaLase Announces Global Commercial Introduction of the FLIGHT Procedure26.5.2026 14:00:00 CEST | Press release
First commercial femtosecond laser image-guided, high precision trabeculotomy (FLIGHT) treatments mark a new era in interventional glaucoma; one where precision, safety, and the patient experience define the new standard of care ViaLase, Inc., a commercial stage medical technology company pioneering incision-free, laser-based solutions for glaucoma, today announced the successful completion of the first commercial FLIGHT procedures performed at Centre for Sight in London by Sheraz Daya, MD, and Gus Gazzard, MD, and at Breyer, Kaymak & Klabe Augenchirurgie in Düsseldorf, Germany, by Karsten Klabe, MD. The first commercial FLIGHT procedures were performed using the ViaLuxe® Laser System to deliver an incision-free, image-guided femtosecond laser treatment designed to create precise channels through the trabecular meshwork to restore aqueous outflow and reduce intraocular pressure in patients with open-angle glaucoma. “Centre for Sight has always been committed to bringing meaningful inno
BioIVT to Spotlight ADME-Tox Expertise and Solutions at Summer 2026 Events26.5.2026 14:00:00 CEST | Press release
Company will demonstrate how high-quality, well-characterized biospecimens are critical to the success of both new approach methodologies (NAMs) and traditional studies BioIVT, the leading biospecimen solutions provider and global research partner for drug and diagnostic development, today announced it will showcase its broad portfolio of ADME-Tox solutions and research expertise at several leading industry events, including the 2026 MPS World Summit and the ISSX 16th European Meeting. The MPS World Summit takes place May 26-May 29, 2026, in Washington, D.C. BioIVT colleagues will be available at booth #115 to discuss research questions and needs, including preparation, handling, and utilization of the high-quality tissues and cells needed for microphysiological systems (MPS), as well as conducting ADME studies and bioanalysis. BioIVT offers an extensive range of control and disease state biospecimens, including SPHEROID CERTIFIED™ Hepatocytes as well as advanced HEPATOPAC® co-cultures
IHS Towers Publishes 2025 Sustainability Report26.5.2026 12:34:00 CEST | Press release
IHS Holding Limited (NYSE: IHS) (“IHS Towers”) group, one of the largest independent owners, operators, and developers of shared communications infrastructure in the world by tower count, has today published its 2025 Sustainability Report. The report covers sustainability activities from January 1, 2025 to December 31, 2025 and demonstrates IHS Towers’ continued commitment to its stakeholders, including, but not limited to, its employees, customers, suppliers, local communities, regulators, governments and shareholders. IHS Towers’ vision is to help create a connected world, where mobile connectivity promotes continued economic growth and social development. The communications infrastructure it provides is vital to enabling that connectivity. In 2025, IHS Towers continued to advance its four-pillar sustainability strategy – focusing on ethics and governance, environment and climate change, education and economic growth, our people and communities – as detailed in this report. Sam Darwi
Compass Pathways to Participate in Jefferies Global Healthcare Conference on June 3, 202626.5.2026 12:30:00 CEST | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will attend the Jefferies Global Healthcare Conference on June 3, 2026 and will participate in a fireside chat at 12:45pm ET. A live audio webcast of this event will be accessible from the “Events” page of the Investors section of the Compass website. A replay of the webcast will be accessible for 30 days following each event. About Compass Pathways Compass Pathways plc (Nasdaq: CMPS) is a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health. We are motivated by the need to find better ways to help and empower people with serious mental health conditions who are not helped by existing treatments. We are pioneering a new paradigm for treating mental health conditions focused on rapid and durable responses through the development of our investigational CO
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
